Results 11 to 20 of about 55,687 (218)

Bio-Memristor Based on Clinical Bile Samples: A Proof-of-Concept Pilot Study for Detection of Gallbladder Cancer. [PDF]

Adv Sci (Weinh)
In this work, we present a bile‐based memristor hardware framework that enables direct, label‐free identification of cholelithiasis and gallbladder cancer at the device level. The Ag/bile/FTO memristor features stable resistive switching and disease‐specific electrical responses, providing a conceptual foundation for circuits and an integrated ERCP ...
Zhu J, Rong Y, Sun B, Sun Z, Wang Y, Ren X, Cao Z, Gao K, Yu J, Wang Z, Ma H, Guo J, Cao K, Kang M, Wang S, Ren F, Lv Y, Lu Q.   +17 more
europepmc   +2 more sources

Human Gallbladder Cancer Organoids. [PDF]

Cell Prolif
This guideline provides standardized requirements and quality control measures for human gallbladder cancer organoids, supporting their reliable application in research and precision medicine. It aims to promote methodological consistency, facilitate international collaboration, and accelerate translational research and clinical implementation.
Xiang D, Gong T, Zhu Y, Jia B, Zhang C, Tang N, Wang W, Wang Y, Zhong L, Zou Y, Zhang J, Zhou Z, Xing L, Zhou C, Zhu D, Liu Z, Chen G, Wang X, Wang Z, He A, Wang Y, Liu Z, Wang J, Xu F, Gao G, Kang X, Gong S, Kong X, Dong C, Ma A, Niu G, Wei G, Zhao H, Lu X, Cao J, Zhao T, Zhang Z, Liu Y.   +37 more
europepmc   +2 more sources

Gallbladder Cancer [PDF]

Surgical Clinics of North America, 2014
Gallbladder cancer remains a relatively rare malignancy with a highly variable presentation. Gallbladder cancer is the most common biliary tract malignancy with the worst overall prognosis. With the advent of the laparoscope, in comparison with historical controls, this disease is now more commonly diagnosed incidentally and at an earlier stage ...
Jessica A, Wernberg, Dustin D, Lucarelli
openaire   +5 more sources

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

Hepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou, Yongkun Sun, Wen Zhang, Jiajia Yuan, Zhi Peng, Wei Wang, Jifang Gong, Lin Yang, Yanshuo Cao, Hong Zhao, Chao Chen, Weifeng Wang, Lin Shen, Aiping Zhou   +13 more
wiley   +1 more source

A Rare Presentation of Gallbladder Carcinoma Metastasis [PDF]

Journal of Clinical and Diagnostic Research, 2014
Gallbladder carcinoma is the 5th most common gastrointestinal cancer. Gallbladder cancer preferentially metastasizes to regional lymph nodes and liver parenchyma. Bone metastases from gallbladder carcinoma are rare presentation.
Sheela Chaudhari, Deepa Hatwal, Pawan Bhat   +2 more
doaj   +1 more source

Controversies and Considerations on Surgical Treatment of Gallbladder Cancer

Zhongliu Fangzhi Yanjiu, 2021
Gallbladder cancer is a high malignancy which is predisposed to invade adjacent organs and have lymph node metastasis. Gallbladder cancer is not sensitive to radiotherapy or chemotherapy with the worst prognosis among biliary tract cancers.
LI Wei, WANG Jinghan, MA Wencong, SHI Xuebing, WU Xiaobing, JIANG Xiaoqing   +5 more
doaj   +1 more source

Neoadjuvant therapy for gallbladder cancer: current status and challenge [PDF]

Waike lilun yu shijian, 2023
Gallbladder cancer is one of highly malignant digestive system tumors with insidious symptoms, rapid progression, and poor prognosis. Although radical resective surgery is the only possible curative way for gallbladder cancer, most patients have lost the
XING Ying, CHENG Shi
doaj   +1 more source

Incidental Gallbladder Cancer: Routine versus Selective Histological Examination After Cholecystectomy

The Surgery Journal, 2021
Background Incidental gallbladder cancer is relatively rare, with an incidence ranging between 0.19 and 5.5% of all the cholecystectomies for benign disease, and carries a poor prognosis. Currently, in the literature, there appears to be some controversy
Andrew Alabi, A D. Arvind, Nikhil Pawa, Shakir Karim, Jason Smith   +4 more
doaj   +1 more source

Prevalence of Gallbladder Cancer in Cases Presented to Tertiary Care Hospital, Retrospective Five-Year Study on Cholecystectomy Specimen [PDF]

Journal of Liaquat National Hospital, 2023
Background: The gallbladder is surgically removed in a cholecystectomy. The prevalence of gallbladder carcinoma is determined by examining cholecystectomy specimens.
Abu Sufyan, Safeena Sarfraz, Qurat ul Ain Tahir, Shahid Farooq, Madiha Arshad, Rabia Altaf   +5 more
doaj   +1 more source

MBD1 promotes the malignant behavior of gallbladder cancer cells and induces chemotherapeutic resistance to gemcitabine

Cancer Cell International, 2019
Background Methyl-CpG binding domain protein 1 (MBD1), which couples DNA methylation to transcriptional repression, has been implicated in transcriptional regulation, heterochromatin formation, genomic stability, cell cycle progression and development ...
Liu Wensheng, Zhang Bo, Hu Qiangsheng, Xu Wenyan, Ji Shunrong, Xu Jin, Ni Quanxing, Yu Xianjun, Xu Xiaowu   +8 more
doaj   +1 more source